SECUKINUMAB SURVIVAL AND SAFETY BASED ON DEMOGRAPHIC CHARACTERISTICS IN SPONDYLOARTHRITIS AND PSORIASIC ARTHRITIS IN A REAL CLINICAL SETTING.

被引：0
|
作者：
Lopez, I. Marta [1 ]
Astigarraga, Uxue [2 ]
Pineiro, Irene [2 ]
Ibarrola, Libe [2 ]
Mendizabal, Javier [2 ]
Sada, Guillen [2 ]
Fito Manteca, Concepcion [2 ]
机构：
[1] Hosp Univ Arava, Vitoria, Spain
[2] Hosp Univ Navarra, Pamplona, Spain
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2023年 / 29卷
关键词：
Safety; Secukinumab; Survival;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PANLAR2023
引用
收藏
页码：S105 / S106
页数：2
相关论文
共 50 条
  • [31] Hepatitis C Direct-Acting Antiviral Treatment Failures: Clinical Characteristics, Outcomes And Resistance Testing From A 'Real-World' Setting.
    Mitchell, Robert A.
    Ou, George
    Leung, Alvina
    Farivar, Jeanette F.
    Howe, Anita
    Ko, Hin Hin
    Ramji, Alnoor
    HEPATOLOGY, 2017, 66 : 854A - 855A
  • [32] Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study
    Peter Foley
    Tsen-Fang Tsai
    Karl Rodins
    Issam Ribhi Hamadah
    Alfred Ammoury
    Hussein Abdel Dayem
    Mahmoud Abdallah
    Susanne Crowe
    Silvia Haas
    Effie Pournara
    Piotr Jagiello
    Yu-Huei Huang
    Dermatology and Therapy, 2022, 12 : 511 - 527
  • [33] Safety of Infliximab Treatment in Patients with Rheumatoid Arthritis in a Real-world Clinical Setting: Description and Evaluation of Infusion Reactions
    Kelsall, John
    Rogers, Pamela
    Galindo, Griselda
    De Vera, Mary A.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1539 - 1545
  • [34] NSCLC Patients Harboring HER2 Mutation: Clinical Characteristics and Management in Real World Setting. EXPLORE GFPC 02-14
    Auliac, Jean Bernard
    Do, Pascal
    Bayle, Sophie
    Doubre, Helene
    Vinas, Florent
    Letreut, Jacques
    Fraboulet, Gislaine
    Falchero, Lionel
    Thomas, Pascal
    Chouaid, Christos
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1271 - S1271
  • [35] The relationship between uveitis in patients with arthritis and demographic and clinical characteristics: A population-based study.
    Mora, Marta
    Lin, Shan
    Masis, Marisse
    Porco, Travis C.
    Oldenburg, Catherine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [36] Efficacy and safety of ixekizumab in psoriatic arthritis: a retrospective, single-centre, observational study in a real-life clinical setting
    Manfreda, V.
    Chimenti, M.
    Canofari, C.
    Esposito, M.
    Perricone, R.
    Bianchi, L.
    Giunta, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (03) : 581 - 582
  • [37] CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS REACHING A HIGH DAILY DOSE OF IDEGLIRA SIX MONTHS AFTER INITIATION IN A REAL-WORLD SETTING
    Prager, R.
    Price, H.
    Blueher, M.
    Fernandes, J.
    Moller, J. B.
    Schultes, B.
    VALUE IN HEALTH, 2018, 21 : S122 - S122
  • [38] BASELINE DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH PLAQUE PSORIASIS TREATED WITH BRODALUMAB IN THE CANADIAN REAL-WORLD SETTING: RESULTS FROM THE CARE STUDY
    Kalia, S.
    Wiseman, M. C.
    Loo, W. J.
    Brassard, D.
    Adam, D. N.
    Kelly, V
    Wong, R.
    Gaudet, V
    Barbeau, M.
    Barakat, M.
    Eberg, M.
    Kalson-Ray, S.
    VALUE IN HEALTH, 2023, 26 (12) : S499 - S499
  • [39] Comparison of demographic and clinical characteristics between opioid-dependent individuals admitted to a community-based treatment setting and those enrolled in a research-based treatment setting
    Carroll, C. Patrick
    Kidorf, Michael
    Strain, Eric C.
    Brooner, Robert K.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2007, 33 (04) : 355 - 361
  • [40] DEMOGRAPHIC AND CLINICAL CHARACTERISTICS AMONG PATIENTS WITH MYELODYSPLASTIC SYNDROMES RECEIVING ORAL DECITABINE AND CEDAZURIDINE OR INTRAVENOUS/SUBCUTANEOUS HYPOMETHYLATING AGENTS IN A REAL-WORLD SETTING
    Zeidan, A.
    Martin, A.
    Costantino, H.
    Modi, K.
    Salimi, T.
    Washington, T.
    Epstein, R.
    LEUKEMIA RESEARCH, 2023, 128
12345